Transcatheter aortic valve implantation: Selection, early mortality, and complications. A multicenter evaluation of more than 33 000 implantations (2013–2023)
The improved short-term results of TAVI from 2013 to 2023 are attributable to a change in patients' risk profiles as well as the increasing experience of the interventionists and refinements of the procedure. The mortality rate, which has remained unchanged in recent years, indicates that the care of older patients with severe aortic stenosis has been largely optimized.
Authors
- Derk Frank (ORCID: https://orcid.org/0000-0001-7561-075X)
- Georg Nickenig
- Won‐Keun Kim (ORCID: https://orcid.org/0000-0002-0799-7478)
- L. Hannen
- Jörg Schröder (ORCID: https://orcid.org/0000-0003-3691-0906)
- Victor Mauri (ORCID: https://orcid.org/0000-0003-2678-3501)
- Mohamed Abdel‐Wahab (ORCID: https://orcid.org/0000-0002-9596-558X)
- Niklas Schofer (ORCID: https://orcid.org/0000-0001-5190-813X)
- Stephan Baldus (ORCID: https://orcid.org/0000-0001-8259-1737)
- Jan Wrobel (ORCID: https://orcid.org/0000-0002-1637-3413)
- Hendrik Wienemann (ORCID: https://orcid.org/0000-0001-5810-2868)
- Henning Guthoff (ORCID: https://orcid.org/0000-0002-0979-1190)
- Jakob Christoph Voran
- Jasmin Shamekhi (ORCID: https://orcid.org/0000-0002-5724-9814)
- Matti Adam
- Tanja K Rudolph
- Karl Finke
Publication Details
- Journal
- Deutsches Ärzteblatt international
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3238/arztebl.m2025.0210
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00